Processa Pharmaceuticals to Participate in a Panel on Interaction with the FDA at the World Orphan Drug Congress Company also to provide a corporate overview in a separate session HANOVER, MD, May 22, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a...

Global Orphan Drugs Market Size – Forecasts to 2028 Brooklyn, New York, Jan. 09, 2023 (GLOBE NEWSWIRE) -- According to a new market research report published by Global Market Estimates, the global orphan drugs market is expected to grow from USD...